Nov 13, 2025 4:30 PM EST Q3 2025 Financial Results Conference Call Participant Dial-in (US): 1-877-407-0792 Participant Dial-in (International): 1-201-689-8263 Webcast Audio Read more
Nov 10 – Nov 14, 2023 American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2023 Read more
Dec 7, 2022 5:00 PM EST Top-line Results from Phase 3 RELIANCE I Trial for REL-1017 as an Adjunctive Treatment for Major Depressive Disorder Conference Call Read more
Feb 23, 2022 8:30 AM EST Relmada Results of Human Abuse Potential Study of REL-1017 vs. Ketamine Read more
Jul 27, 2021 8:30 AM EST Top-Line Results of Study Evaluating REL-1017 vs Oxycodone for Abuse Potential
Apr 27 – Apr 30, 2021 American Society for Pharmacology and Experimental Therapeutics Annual Meeting at Experimental Biology 2021
Oct 15, 2019 8:30 AM EST Conference Call to Discuss Results of Phase 2 Study of REL-1017 for Treatment Resistant Depression